Semintra: The Ph, Appearance And Assay Is Out Of Specification In The Affected Lot.

Semintra medication from an affected lot has quality issues where the pH level, appearance, and chemical content don't meet specifications. The product was distributed across Canada. This is classified as a serious quality concern by the manufacturer.

Product

Semintra

Reason

Product quality

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2023-10-25

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/65630239-4375-40fe-9708-4949e2510faf